Page last updated: 2024-08-21

medroxyprogesterone and Carcinoma, Ductal, Breast

medroxyprogesterone has been researched along with Carcinoma, Ductal, Breast in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kawahara, H; Sakurai, T; Tatematsu, H; Yamamoto, T; Yamataka, K	1

Other Studies

1 other study(ies) available for medroxyprogesterone and Carcinoma, Ductal, Breast

Article	Year
[Results of treatment based on endocrine therapy for bone metastasis from breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2001, Volume: 28, Issue:13 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Epirubicin; Female; Gonadotropin-Releasing Hormone; Humans; Medroxyprogesterone; Middle Aged; Palliative Care; Progesterone Congeners; Quality of Life; Survival Rate	2001

Article

Year

[Results of treatment based on endocrine therapy for bone metastasis from breast cancer].

Gan to kagaku ryoho. Cancer & chemotherapy, 2001, Volume: 28, Issue:13

Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Epirubicin; Female; Gonadotropin-Releasing Hormone; Humans; Medroxyprogesterone; Middle Aged; Palliative Care; Progesterone Congeners; Quality of Life; Survival Rate

2001